Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Lancet
Jeffrey B WashamROCKET AF Steering Committee and Investigators

Abstract

Digoxin is a widely used drug for ventricular rate control in patients with atrial fibrillation (AF), despite a scarcity of randomised trial data. We studied the use and outcomes of digoxin in patients in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). For this retrospective analysis, we included and classified patients from ROCKET AF on the basis of digoxin use at baseline and during the study. Patients in ROCKET AF were recruited from 45 countries and had AF and risk factors putting them at moderate-to-high risk of stroke, with or without heart failure. We used Cox proportional hazards regression models adjusted for baseline characteristics and drugs to investigate the association of digoxin with all-cause mortality, vascular death, and sudden death. ROCKET AF was registered with ClinicalTrials.gov, number NCT00403767. In 14,171 randomly assigned patients, digoxin was used at baseline in 5239 (37%). Patients given digoxin were more likely to be female (42% vs 38%) and have a history of heart failure (73% vs 56%), diabetes (43% vs 38%), and persistent AF (88% vs 77%; p<0·0001 for each comparison). Afte...Continue Reading

References

Feb 20, 1997·The New England Journal of Medicine·UNKNOWN Digitalis Investigation Group
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Feb 18, 2003·JAMA : the Journal of the American Medical Association·Saif S RathoreHarlan M Krumholz
Sep 6, 2006·Heart·A J CammUNKNOWN Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation
Aug 9, 2007·European Journal of Clinical Pharmacology·Pär HallbergUNKNOWN RIKS-HIA group
Sep 30, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·A John CammUNKNOWN ESC Committee for Practice Guidelines
Mar 11, 2011·The New England Journal of Medicine·UNKNOWN ACTIVE I InvestigatorsStuart J Connolly
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Apr 28, 2012·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Jonathan P PicciniLesley H Curtis
Nov 29, 2012·European Heart Journal·Matthew G WhitbeckClaude S Elayi
Sep 3, 2013·Expert Review of Cardiovascular Therapy·Connie N HessRenato Lopes
Nov 1, 2013·Journal of the Saudi Heart Association·Ahmad S HersiJassim Al Suwaidi
Dec 19, 2013·Circulation·Sumeet S ChughChristopher J L Murray
Jun 14, 2014·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Bart A MulderUNKNOWN RACE II Investigators

❮ Previous
Next ❯

Citations

Jan 5, 2016·Nature Reviews. Cardiology·Laurent Macle, Stanley Nattel
Aug 21, 2015·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Frank Xavier ScheuermeyerKarin Humphries
Mar 26, 2016·Medicine·Wu-Tao ZengYun-Jiu Cheng
May 29, 2016·International Journal of Cardiology·Mohamed MetaweeUNKNOWN Magic investigators
Aug 18, 2016·Frontiers in Physiology·Anna BogdanovaAntonio Martínez-Ruiz
Aug 26, 2016·Lancet·Isabelle C Van GelderBrian Olshansky
Sep 10, 2016·The Canadian Journal of Cardiology·Laurent MacleUNKNOWN CCS Atrial Fibrillation Guidelines Committee
Oct 28, 2016·Journal of Clinical Pharmacy and Therapeutics·M BitekerC Kırma
Sep 24, 2016·Therapeutic Advances in Cardiovascular Disease·Sarah L TurleyWilliam D Cahoon
Jul 13, 2016·Journal of the American Heart Association·Alon EisenRobert P Giugliano
May 14, 2017·Circulation. Arrhythmia and Electrophysiology·Demilade AdedinsewoAnekwe Onwuanyi
Sep 14, 2018·Current Cardiology Reports·Jeffrey B Washam, Manesh R Patel
Jun 21, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Eitaro KodaniUNKNOWN J-RHYTHM Registry Investigators
Nov 22, 2018·American Journal of Therapeutics·Wilbert S Aronow, Tatyana A Shamliyan
Jan 14, 2020·Expert Opinion on Pharmacotherapy·Ashish CorreaWilbert S Aronow
Apr 11, 2018·Arrhythmia & Electrophysiology Review·Pascal VranckxHein Heidbuchel
Apr 20, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kieran L QuinnUNKNOWN Canadian Drug Safety and Effectiveness Research Network (CDSERN)
Jun 19, 2019·European Heart Journal·Lukas Aguirre DávilaArmin Koch
Jan 10, 2017·European Heart Journal·Udo BavendiekJohann Bauersachs
Jun 6, 2018·Frontiers in Pharmacology·Kuan-Cheng LaiChia-Hung Kao
Feb 25, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Gerrit FrommeyerLars Eckardt
Jul 22, 2019·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Giuseppe BorianiA John Camm
Feb 17, 2017·European Heart Journal. Cardiovascular Pharmacotherapy·Gianluigi Savarese, Lars H Lund
Nov 17, 2017·Circulation Journal : Official Journal of the Japanese Circulation Society·Hee Tae YuBoyoung Joung
Dec 6, 2018·Cardiovascular Toxicology·Christian EllermannGerrit Frommeyer
Jun 27, 2019·Current Cardiology Reviews·Filipe FerrariRicardo Stein
Dec 8, 2019·International Journal of Clinical Oncology·Yosuke SugiyamaKazunori Kimura
Jan 19, 2016·Global Cardiology Science & Practice·Mohamed ElMaghawry
Nov 3, 2017·The New England Journal of Medicine·Mitsuaki SawanoKeiichi Fukuda
May 12, 2019·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Ying GaoChangsheng Ma
Dec 9, 2020·Wiener klinische Wochenschrift·Mehmet Baran KarataşAyşe Emre
Dec 18, 2020·Journal of Cardiovascular Electrophysiology·Annabelle Santos VolgmanUNKNOWN American College of Cardiology Committee on Cardiovascular Disease in Women
Nov 24, 2020·Hellenic Journal of Cardiology : HJC = Hellēnikē Kardiologikē Epitheōrēsē·Panagiotis N MargosAlexandros S Stefanidis
Jan 28, 2021·The New England Journal of Medicine·Gregory F Michaud, William G Stevenson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Related Papers

© 2022 Meta ULC. All rights reserved